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Fluorescence in situ hybridizationIntellectual disability (ID) is a common disease. While the etiology remains incompletely understood, genetic
defects are a major contributor, which include mutations in genes encoding zinc ﬁnger proteins. These pro-
teins modulate gene expression via binding to DNA. Consistent with this knowledge, we report here the iden-
tiﬁcation of mutations in the ZNF407 gene in ID/autistic patients. In our study of an ID patient with autism, a
reciprocal translocation 46,XY,t(3;18)(p13;q22.3) was detected. By using FISH and long-range PCR ap-
proaches, we have precisely mapped the breakpoints associated with this translocation in a gene-free region
in chromosome 3 and in the third intron of the ZNF407 gene in chromosome18. The latter reduces ZNF407
expression. Consistent with this observation, in our subsequent investigation of 105 ID/autism patients
with similar clinical presentations, two missense mutations Y460C and P1195A were identiﬁed. These muta-
tions cause non-conservative amino acid substitutions in the linker regions between individual ﬁnger struc-
tures. In line with the linker regions being critical for the integrity of zinc ﬁnger motifs, both mutations may
result in loss of ZNF407 function. Taken together, we demonstrate that mutations in the ZNF407 gene contrib-
ute to the pathogenesis of a group of ID patients with autism.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Intellectual disability is a disease that manifests as a signiﬁcant de-
cline in acquiring knowledge, processing complex information, and
independently solving problems [1,2]. ID affects approximately 2–3%
of the human population and occurs more in males than in females
[3]. Despite its prevalence, therapeutic options for ID patients are
very limited. Furthermore, for at least 50% of ID cases the etiology re-
mains unknown. ID is caused by many complex factors. While envi-
ronment factors, including malnutrition and education, contribute
to ID, accumulating research demonstrated that ID is mainly caused, 50 Charlton Ave East, Hamilton,
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rights reserved.by genetic defects, including chromosomal abnormalities and gene
mutations [4,5].
The genetic defects that are commonly associated with ID can be
generally divided into two major categories. Genetic abnormalities
can lead to syndromic ID in which patients show additional clinical
presentations, including radiological, metabolic or biological features.
Genetic defects can also cause nonsyndromic or nonspeciﬁc ID in
which cognitive impairment represents the only consistent manifes-
tation [6]. Despite the fact that many genes have been identiﬁed to as-
sociate with syndromic and nonsyndromic ID, more ID genes remain
to be discovered [7].
Since reproduction is a rare event for ID patients, the disease hardly
occurs in a family-clustering pattern, i.e., multiple members of a family
being diagnosedwith ID. Exceptions are thegenetic defects that are asso-
ciated with the X-chromosome or have either recessive or dominant
traits in ID patients. Therefore, the lack of family manifestation makes
identifying ID candidate genes using genetic linkage analysis difﬁcult.
An alternative methodology used to search for ID candidate genes is
the investigation of chromosome translocation or inversion. This analysis
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identify ID candidate genes by the examination of a single case of IDwith
chromosome translocation or inversion [8].
In our effort to search for ID candidate genes,we have recently exam-
ined a nonsyndromic ID/autistic patient with karyotype 46,XY,
t(3;18)(p13;q22.3). The patient was diagnosed with ID that was associ-
atedwith autistic phenotypes, includingdelay in language development.
Through molecular analysis of the chromosome breakpoints, we were
able to precisely map the breakpoint in chromosome 18 to the third in-
tron of the ZNF407 gene. As a result of this translocation, the transcrip-
tion of the ZNF407 isoform 1 gene, an isoform gene that contains the
intron 3, is signiﬁcantly reduced. In our subsequent examination of
105 patients with similar clinical features for mutations in the ZNF407
gene, two potentially harmful missense mutations were identiﬁed.
2. Materials and methods
2.1. The patient population used in this investigation
A patient with the balanced chromosome translocation [46,XY,
t(3;18)(p13;q22.3)], an 8 year old boy, was brought to our clinic by
his parents for delay in his intelligence development. At the time,
his IQ was scored at 60 according to the WAIS Intelligence Test for
Children. The patient was impaired in language development and
was unable to speak with a clear voice. His memory ability was sub-
stantially reduced and his performance in school was poor. The
child was not socializing with his peers and was unable to focus his
attention. The child started to sit and walk at 11 months and
2 years old, respectively. He was enrolled in a pre-school program
at 8 years of age with the ability to count numbers from 1 to 10. At
13 years of age, the boy could only write his name, expressed himself
very poorly, and was able to complete simple mathematic tasks with
plus and minus for numbers not exceeding 10. His IQ was 58. He was
unable to communicate or socialize with his classmates. The boy was
capable of completing simple tasks and managing his daily activities.
His physical conditions were sound. Brain MR did not detect any ab-
normalities. Additional clinical and experimental tests eliminated
his conditions from the fragile X syndrome and other ID syndromes.
The child was the second normal birth from a healthy and non-
consanguineous couple. There was no history of using medicines,
alcohol consumption, and exposure to toxic materials during the
pregnancy. After birth, the boy did not experience asphyxiation,
fever, hyperspasmia, and bilirubin encephalopathy.
We have subsequently recruited 105 patients (77 males and 28 fe-
males) with non-syndromic intellectual disability. These patients
exhibited similar clinical features as the above patient, including
moderate deﬁciencies in social communications, delays in language
development, and IQ between 49 and 78; 68 of the 105 patients
displayed attention deﬁcient hyperactivity disorder, and 35 of the
105 patients have epilepsy history. All patients did not have any de-
tectable organ malformation. Two hundred normal individuals (109
males and 91 females) were also selected as controls.
2.2. Isolation of genomic DNA
Genomic DNA from the patient with the reciprocal chromosome
translocation, his parents, the 105 ID patients, and 200 control individ-
uals was isolated by standard protocols. Samples were collected with
consent. Genomic DNA samples were used for mutation screening.
2.3. Array CGH
Genomic DNA was isolated from the patient [46,XY,t(3;18)(p13;
q22.3)] and his parents. Array CGH was carried out by using a com-
mercial service. Chromosomal microarray analysis (CMA) or array
comparative genomic hybridization (aCGH) was performed by usingthe Agilent 8×60K human whole genome microarray that was
designed by The International Standard Cytogenomic Array (ISCA)
Consortium and modiﬁed by Oxford Gene Technology (OGT). The mi-
croarray contains approximately 60,000 oligonucleotide (60 mer)
probes with enhanced coverage for the known microdeletion and
microduplication syndromes, subtelomeric, and pericentric regions.
The average spatial resolution is about 5–10 kb for the targeted re-
gions and 75 kb for the backbone genomic regions. Pooled sex
matched DNAs from individuals with normal aCGH results were
used as controls. The microarray technology detects deletions, dupli-
cations, chromosome aneuploidies, and mosaicism (>20%), but does
not detect balanced chromosome rearrangements (such as reciprocal
translocations, Robertsonian translocations, and inversions), triploi-
dy, small genomic imbalances, and point mutations.
2.4. Karyotype and FISH analysis
Karyotype analysis was performed by using standard high resolu-
tion techniques. For mapping the breakpoints, we used probes derived
from BAC clones that were selected from the University of California–
Santa Cruz (UCSC). BACs were purchased from the Children's Hospital
Oakland Research Institute in Oakland, California, USA. BAC DNA was
prepared by standard techniques and labeled with appropriately
coupled dUTPs by nick translation (Vylsis). Chromosome denaturation,
hybridization, and signal detection were done according to the
manufacturer's instructions. Slides were analyzed by using an Olympus
BX60 ﬂuorescence microscope equipped with appropriate ﬁlters and a
LUCIA Cytogenetics 4.81 image analysis system.
2.5. Long-range PCR, DNA sequencing, and breakpoint determination
Based on FISHanalysis using over lapping BACprobes, the breakpoints
on chromosomes 3 and 18 were narrowed down. Primers were then
designed by using software Prime 5 and subsequently synthesized by
Invitrogen. The strategy used to amplify the regions containing the
breakpoints was pairing the breakpoint-speciﬁc primers to chromosome
3 or 18 speciﬁc primers (Supplementary Table A1). Long-range PCR reac-
tions were performed by using TaKaRa LA Taq hot start version Kit
(TaKaRa Biotechnology, Dalian) according to the manufacturer's instruc-
tions. PCR products were then sequenced (Beijing Genomics Institute).
Based on the DNA sequences derived from chromosomes 3 and 18,
breakpoints were then deﬁned.
2.6. RNA isolation and real-time RT-PCR
Total RNA was isolated from lymphocytes or oral mucosa cells
obtained from the patient with the reciprocal chromosome transloca-
tion and from his parents by using Trizol (Invitrogen), according to the
manufacturer's protocol. RNA was also prepared from lymphocytes
present in control blood samples. First-strand cDNA was synthesized
from total RNA by using oligo(dT)20 and M-MLV reverse transcriptase
(RT, Invitrogen). Real-time RT-PCR reactions were then performed
according to standard protocols in a 25 μl ampliﬁcation mixture
containing 12.5 μl of 2× Reaction Mix, 0.5 μl RT Platinum® Taq Mix
(Invitrogen), 0.5 μl of each primer (10 μM), 0.2 μl probe (10 μM) and
5 μl RNA by using the ABI 7500 (Applied Biosystems, Foster City, CA).
Ampliﬁcation of the isoforms 1, 2, and 3 of ZNF407 was performed by
using isoform speciﬁc primers (Supplementary Table A2) and the ex-
pression values of ZNF407 isoforms were normalized to both actin and
TBP (TATA-box binding protein). Each assay included non-template
controls and unknown samples in triplicate for the patient with a bal-
anced translocation, his parents and normal controls. All experiments
were repeated three times. Statistical analysis was performed by using
Student's t-test (2-tails) and a P valueb0.05 was considered statistically
signiﬁcant.
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Screening for mutations in ZNF407 for 105 patients who had sim-
ilar clinic phenotypes as the patient with chromosome translocation
in comparison to the 200 normal controls was carried out by using
PCR ampliﬁcation coupled with DNA sequencing technology. PCR
primers and conditions used are summarized in Supplementary
Table A3. All mutations in patients were deﬁned by a comparison to
the population of normal controls, including their parents.3. Results
3.1. The translocation occurred between chromosomes 3 and 18
In our effort to examine the chromosome abnormality associated
with a patient (Supplementary Fig. A1(A)), we were able to identify
the patient's karyotype being 46,XY,t(3;18)(p13;q22.3) (Supplementary
Fig. A1(B)). As the karyotyes for both his parents were normal, the trans-
location between chromosomes 3 and 18 in the patient was a de novo
event, i.e., not inherited from his parents.
To determine whether the patient was also associated with other
genomic changes, we have performed array CGH for the genomic
DNA derived from the patient and his parents. No apparent abnor-
malities were detected in all DNA samples. These results revealed
that this patient did not have copy number variations (CNVs) and
did not have gain or loss of a large chunk of genomic DNA. Therefore,
the clinical features of this ID/autism patient were most likely caused
by the reciprocal translocation between chromosomes 3 and 18.Fig. 1. Identiﬁcation of the BAC clones spanning the breakpoints in chromosomes 3 and 18.
using the indicated chromosome 3 (ch3) and 18 BAC clones. (C) A schematic illustration sho
in the patient. Arrows indicate the break regions that are within the BAC PR11-141013 (ch3.2. Identiﬁcation of BACs containing the breakpoints occurred in chro-
mosomes 3 and 18
The above results strongly suggest that the breakpoints in chro-
mosomes 3 and 18 as well as the subsequent chromosome transloca-
tion may affect the expression of ID candidate genes. To identify these
candidate genes, we have ﬁrst narrowed down the breakpoints by
using a chromosome walk technique. A set of BAC clones speciﬁc for
chromosome 3 (Supplementary Table A4) were selected to perform
FISH analysis in a step-wise manner. By using this approach, we
were able to narrow down the breakpoint in chromosome 3 to BAC
RP11-806H15 and BAC RP11-141O13 and thus the maximal region
in which the break occurs (Supplementary Fig. A2). In supporting
the aforementioned BAC clones spanning across the breakpoint in
chromosome 3, we were able to show that both BAC RP11-806H15
(data not shown) and RP11-141O13 detected the normal chromo-
some 3 and produced split signals in derivative chromosomes 3 and
18 (Fig. 1A). As RP11-806H15 (chr3: 70635936–70827471) and
RP11-141O13 (chr3:70705065–70868726) were derived from 3p13
(Supplementary Fig. A2), the breakpoint in chromosome 3 thus oc-
curred in the 3p13 region (Fig. 1C).
Following the same strategy, we ﬁrst located the breakpoint in
chromosome 18 to BACs RP11-460I23, RP11-124M6, and RP11-27C7
(Supplementary Fig. A3) by using a set of chromosome 18 BAC clones
(Supplementary Table A5). Subsequently, BACs RP11-46OI23
(chr18:72397229–72598462) (data not shown), RP11-124M6
(chr18:72403650–72575460) (data not shown) and RP11-27C7
(ch18: 72506340–72656498) were found to be able to recognize sig-
nals existing in 18 as well as in derivative chromosomes 3 and 18(A), (B) Fish analysis of chromosomes 3 and 8 in the 46,XY,t(3;18)(p13;q22.3) patient
wing the normal chromosomes 3 and 18 along with their derivative (der) counterparts
3) and BAC PR11-27C7 (ch18), respectively.
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A3), demonstrating that a break occurred in this region (Fig. 1C).3.3. Chromosomes 3 and 18 were broken in a gene-free region and in the
ZNF407 gene, respectively
With the BAC clones spanning the breakpoints in chromosomes 3
and 18 identiﬁed (Fig. 1, Supplementary Fig. A2 and A3), we ﬁrst
attempted to map the breakpoint in chromosome 3. By using long
range PCR with a combination of different primers, we successfully
obtained a PCR amplicon of approximately 1000 base pairs (bp)
from the derivative chromosome 3 by using a chromosome 3 primer
L3p-1R and a chromosome 18 primer L18q-1R (Supplementary Fig.
A4, lane 2). As expected, this pair of primers failed to yield detectable
PCR products from the DNA template that was derived from a normal
individual (Supplementary Fig. A4, lane 1). DNA sequencing con-
ﬁrmed that the PCR product consisted of DNA sequences derived
from chromosomes 3 and 18 (Fig. 2A). As the nucleotide GA in the
junction region of the derivative chromosome 3 (Fig. 2A) could not
be assigned to either chromosome 3 or 18, we concluded that the
break took place between nucleotides 70789412–70789414 (Human
Genome Sequences, Build 37.1) in chromosome 3. Since no known
genes reside in this region, the break at chromosome 3 lies within a
gene-free region.Fig. 2. Identiﬁcation of chromosome breakpoints. Representative images show the DNA seq
the derivative chromosome 18 (B). The proportion of DNA sequence derived from the base
mosome 3 (B) is indicated. The two nucleotides bordered by the two vertical lines could no
to either chromosome was based on the human genome sequences present in Build 37.1. (C
are adjacent to the breakpoints, of the normal chromosome (Chr) 18 (the plus strand) and
dicate the potential loss of nucleotides that were resulted from the reciprocal translocationWith the knowledge of the breakpoint sequences in derivative chro-
mosome 3, we were able to build a pair of primers (L18d-18F,L18d-3F)
to obtain an amplicon of ~700 bp that encompassed the breakpoint re-
gion in derivative chromosome 18 (Supplementary Fig. A4, lane 3). The
ampliconwas subsequently sequenced and the junction sequenceswere
determined (Fig. 2B). Again the junction nucleotide CT could not be
assigned to individual chromosomes with conﬁdence. The breakpoint
on chromosome 18 was thus deﬁned between nucleotides 72547010–
72547012 (Human Genome Sequences, Build 37.1) (Fig. 2B). These se-
quences are within the third intron of the ZNF407 gene.
We then examined whether these break and translocation events
resulted in the loss or deletion of the DNA sequence in either chromo-
some 3 or 18. In comparison to wild type chromosomes 3 and 18, we
were able to conclude that the breaks and translocation resulted in
the loss of 4–8 nucleotides in chromosome 18 and 2–6 nucleotides
in chromosome 3 (Fig. 2C).3.4. The translocation between chromosomes 3 and 18 reduces the ex-
pression of ZNF407 isoform 1
From mapping the breakpoint in chromosome 18 to the third in-
tron of ZNF407, we went on to examine whether this break and the
subsequent chromosome translocation may affect the ZNF407 gene
expression. The ZNF407 protein consists of three isoforms (Fig. 3A).uence surrounding the fusion sites in the derivative chromosome 3 (Der Chr3) (A) and
chromosome 3 or 18 and derived from the translocated chromosome 18 (A) or chro-
t be precisely assigned to either chromosome. The assignment of nucleotide sequence
) Analysis of the junctions in derivative chromosomes 3 and 18. DNA sequences, which
3 (the minus strand) are shown. The gaps present in the derivative chromosomes in-
.
Fig. 3. The reciprocal t(3;18)(p13;q22.3) translocation signiﬁcantly reduces the ex-
pression of isoform 1 but not isoform 3 ZNF407. (A) A schematic illustration of the
three isoforms of ZNF407. The two mutated residues Y460 and P1195 are within the
exon 1. The vertical dot–line indicates the position of the breakpoint. Exon 3 and intron
3 are also indicated. (B) RNA was extracted from peripheral blood samples obtained
from the patients with t(3;18)(p13;q22.3) and normal controls, including his parents.
Real time RT-PCR was performed to analyze the expression of isoforms 1, 2, and 3
ZNF407 by using isoform speciﬁc primers. The isoform 2 transcript was undetectable
(data not shown). The abundance of isoform 1 and 3 ZNF407 transcripts was normal-
ized to either actin or TBP, which produced similar results. Data used here were nor-
malized to TBP. Experiments were repeated at least three times. Data are presented
as the mean fold changes±SD to the speciﬁc isoforms in the normal individuals.
*pb0.05 (2-tail Student's t-test) in comparison to normal individuals.
Table 1
Sequence alterations in the ZNF407 DNA in a patient with MR and autism.
Exon and
nucleotide change
Amino acid
change
Number of patients
with the change
Numbers of
normal people
1 c.263A>G N69S 6 0/100
1 c.1436A>G Y460C 1 0/200
1 c.2972A>C N972T 32 30/100
1 c.3640C>G P1195A 1 0/200
8 c.6112G>C V2019L 1 0/200
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isoform 3 does not (Fig. 3A). To determine the impact of the break
in the third intron of the ZNF407 gene on the expression of the
ZNF407 isoforms, we have performed real time PCR analysis of RNA
puriﬁed from the peripheral blood samples obtained from this patient
and his parents by using isoform speciﬁc primers (Supplementary
Table A2). After normalizing to either actin or TBP, real time PCR anal-
ysis clearly demonstrated an approximate 40% reduction in the iso-
form 1 ZNF407 transcript in the patient in comparison to normal
individuals, including the patient's parents (Fig. 3B). The isoform 2
transcript was undetectable (data not shown), suggesting that iso-
form 2 may not be expressed or expressed at a very low level in the
peripheral blood. The isoform 3 was expressed at comparable levels
in the patient and his parents (Fig. 3B), which is consistent with the
genomic region that encodes isoform 3 which lies proximal to the
breakpoint (Fig. 3A). Taken together, the above observations reveal
that the break in the intro 3 reduces the expression of the isoform 1
ZNF407.
3.5. Mutations in the ZNF407 gene in ID patients
The observed reduction in the expression of the isoform 1 ZNF407 in
an ID/autistic patient with t(3;18)(p13;q22.3) suggests that changes in
the ZNF407 expression play a role in the pathogenesis of ID/autism. To
further investigate this possibility, we have analyzed mutations in the
ZNF407 gene in a total of 105 patientswith a similar clinical presentation.
This analysis focused on the 5′UTR (un-transcribed region), exons, junc-
tions between exons and introns, and 3′ UTR regions. A total of 5
misssense mutations were found in 41 patients (Table 1). Among them
6 patients had 263 A>G substitution and 32 patients contained 2972
A>Cmutation (Table 1). These two frequent variations have previously
been reported as polymorphisms in the SNP database (rs948615,
rs3794942). The missense mutation 6112G>C (V2019L) (Table 1) also
resulted from polymorphism, because this variation was detected in
the patient's father (a normal individual). The rest of the two variations
1436 A>G (Y460C) and 3640 C>G (P1195A) (Fig. 4A, B, Table 1) were
de novo missense mutations as they were not reported and were not
detected in the population of normal control individuals, including
their parents. These two residues Y460 and P1195 are highly conserved
among the ZNF407 proteins in different species (Fig. 4C). The exception
is P1195 being L in gallus, which suggests that ZNF407 may not be in-
volved in “intelligence” development in gallus. Both the mutations
Y460C and P1195A resulted in the substitution of an amino acid residue
with a benzene ring group (tyrosine Y andphenylalanine P)with either C
(being able to form a disulﬁde bond) or small residue alanine (A). These
changes are therefore rather dramatic, which is highly expected to im-
pact protein structure. This notion is in line with the prediction by
PolyPhen and Jpred3 software, which indicated changes in α-helix
(data not shown). Furthermore, both residues Y460 and P1195 reside
in the linker regions between the ﬁnger structures of the zinc ﬁnger
motif (Supplementary Fig. A5) and amino acid identities in these linker
regions play critical roles in the function of zinc ﬁngers [9,10]. Taken to-
gether, these two missense mutations are likely to interfere with the
ZNF407's function.
3.6. The ID patient with 46,XY,t(3;18)(p13;q22.3) does not have muta-
tions in the ZNF407 gene and contains no CNVs in chromosomes 3 and 18
In view of the additional mutations detected in the 105 ID pa-
tients, it is intriguing to examine whether the ZNF407 gene in the ID
patient with the reciprocal translocation contains mutations in addi-
tion to the breakpoint identiﬁed in the third intron. For this purpose,
we have sequenced the intact ZNF407 gene in this patient. No muta-
tions were detected (data not shown). This suggests that a decrease
in the expression of isoform 1 ZNF407 is sufﬁcient to attenuate the
protein's function.As a result of the reciprocal translocation, it is possible that copy-
number variations (CNVs) may occur in chromosomes 3 and 8 or
even in the ZNF407 locus. To examine this possibility, we have carried
out array CGH speciﬁc for chromosome 3 or 8. The results revealed no
obvious CNVs being detected in either chromosome 3 or 8 (Fig. 5).
There were also no CNVs in the ZNF407 locus (Fig. 5B, the enlarged
panel). These observations are consistent with our genome array
CGH analysis, which did not show any major genome abnormalities
(data not shown) in this patient. Taken together, the above observa-
tions support the concept that reduction of the transcription of the
ZNF407 gene in the ID patient with the reciprocal translocation is suf-
ﬁcient to cause the ID/autistic phenotype.
4. Discussion
One of the common genetic methodologies used in the identiﬁcation
of disease-associated genes is the investigation of reciprocal chromosome
Fig. 4. Identiﬁcation of two mutations in 105 ID and autistic patients. Arrows show the substitution of C with G at codon 3640 resulting in change of Pro1195 to Ala (A) and the
replacement of nucleotide 1436A with G leading to the substitution of amino acid residue Tyr460 with Cys (B). (C) Alignment of ZNF407 in the regions containing Y460 (boxed
residue, top panel) and P1195 (boxed residue, bottom panel). Both residues are highly conserved among these spices.
436 C. Ren et al. / Biochimica et Biophysica Acta 1832 (2013) 431–438translocations that lead to disease presentation. During the study of a fe-
male ID case and the analysis of additional three families with ID, OPHN1
gene was identiﬁed as an ID-causing gene in 1998 [11]. Since then, nu-
merous genes that are associated with ID have been identiﬁed by using
this methodology. These genes were almost exclusively X chromosome-
linked, including SMC1A, ZNF81, KIAA1202, ZNF41, CDKL5, TM4SF2,
DCX, GRIA3, OCRL1, ARHGEF6, and ARHGEF9. Instead, one autosomal ID
gene GLI3 at 7p13 was identiﬁed by studying chromosome breakpoints
[12]. By investigating chromosomal breakpoints that are associated with
reciprocal chromosome translocations, numerous ID candidate genes
have been reported, including NTNG1, ZNF462, ASXL2, GPD2, SATB2,
JNK3, CDKL3, SNX3, TCBA1, AUTS2, MLLT3, DOCK8, FOX1, PAFAH1B3,
GRPR, ZNF261, ZDHHC15, TCF4, CHD6, PPP2R2C, FUS/TLS, and KCNMA1
[13–18]. Except GRPR, ZNF261, and ZDHHC15 being X chromosomal
gene, the rest are autosomal genes.
Consistent with these studies, in our recent investigation of an
ID/autistic case with a reciprocal translocation between chromosomes
3 and 18, we successfully mapped the breakpoint sequences. Our
array CGH for genome as well as speciﬁc for chromosomes 3 and 18did not ﬁnd major genome abnormalities in 46,XY,t(3;18)(p13;q22.3)
ID/autistic patient. It is therefore likely that his ID/autistic phenotype
was caused by the reciprocal translocation and its associated chromo-
some breaks. The breakpoint on chromosome 3 did not directly disrupt
any known genes and the translocation did not result in CNVs in chro-
mosome 3 (Fig. 5A). However, we cannot exclude the possibility that
this break may affect the structure of chromosome 3, and thereby
causes changes in the expression of genes residing in chromosome 3.
These changes may in turn contribute to ID conditions. Further experi-
ments will be needed to address this possibility.
The breakpoint in chromosome 18 in the third intron of the
ZNF407 gene disrupted the gene, a member of the zinc ﬁnger protein
family. The family consists of a large number of proteins. Based on the
difference in the conserved structure region, zinc ﬁnger proteins can
be divided as C2H2, C4, and C6 type.
According to the UniProt-based prediction, the ZNF407 protein con-
tains 22 C2H2 structure (Supplementary Fig. A5). C2H2 zinc ﬁnger was
initially identiﬁed in the transcriptional factor TFIIIA from Xenopus
laevis. This type of zinc ﬁnger is one of the most common DNA binding
Fig. 5. No CNVs were detected in chromosomes 3 and 18 in the t(3;18)(p13;q22.3) ID/
autistic patient. Array CGH analysis of chromosome 3 (A) and chromosome 18 (B). The
boxed region (B) is enlarged (underneath) to show the details in the region containing
the ZNF407 gene.
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pend on the amino acid sequence that links individualﬁngers, the num-
ber of ﬁnger structures, and the overall structure. Consistent with this
concept, the two point mutations that we have identiﬁed in the
ZNF407 gene, P1195A and Y460C, arewithin the linker regions (Supple-
mentary Fig. A5). Therefore, it is tempting to propose that both muta-
tions may cause the protein's structural changes, and thereby affecting
ZNF407 protein function. This notion is in line with the observed ap-
proximate 40% decrease in the transcription of isoform 1 ZNF407 in
the 46,XY,t(3;18)(p13;q22.3) ID/autistic patient and this patient con-
tains no mutations that lead to amino acid substitutions. Therefore, it
is possible that attenuation of ZNF407 due to eithermutations or reduc-
tion of its expression as the result of potential haploinsufﬁciency is a
pathological cause for the ID/autistic phenotype. Furthermore, it is in-
triguing to notice the level of the isoform 1 ZNF407 expression which
was at approximately 60% of that in normal individuals. Since once
copy of the isoform 1 gene was disrupted as the result of the break
and translocation in the ID/autistic patient with the reciprocal translo-
cation (Fig. 3A), the wild type copy of the ZNF407 gene might try to
compensate the loss. Collectively, the above discussions suggest thatthe ZNF protein is functionally important in preventing the pathogene-
sis of ID/autism.
The ZNF407 function in this process might be in part attributable
to isoform 1. Despite the mutations P1195A and Y460C occurring in
the exon1 that is shared by three isoforms (Fig. 3A), the observation
that the isoform 3 expression was not affected in the 46,XY,
t(3;18)(p13;q22.3) patient reveals that the isoform 3 may not play
a major role in intelligence development. However, whether the iso-
form 2 contributes to this development needs further investigation.
Our ﬁnding that the ZNF407 zinc ﬁnger protein plays a role in ID
pathogenesis is consistent with reports of zinc ﬁnger genes being in-
volved in ID diseases [19–22]. ZNF81 was deﬁned as an ID candidate
gene based on the analysis of an X chromosome breakpoint as well
as the mutational linkage study of 300 families with XLID (X-linked
intellectual disability) [19]. Systematic analysis of the X chromosome
in XLID families by using array CGF identiﬁed ZNF674 as being associ-
ated with ID [21]. These observations are generally in line with the
demonstration that the zinc ﬁnger proteins ZNF592 and ZC3H14
play roles in brain development and neuron functions [22,23].
Consistent with the ZNF407 genes residing in 18q22.3, deletion of a
region within the 18q22.3–23 region was observed in a mild ID patient
[24].While deletion of a 3.21 Mb region (70,079,559–73,287,604)with-
in 18q22.3–23 that encompasses ZNF407whichwas reported to associ-
atewith kidneymalformation [25], we did not observe any deﬁciency in
the kidney function in the 46,XY,t(3;18)(p13;q22.3) ID and this patient
did not show any organ malformation. Therefore, it is unlikely that the
ID/autistic phenotype displayed in this patient was indirectly caused by
malfunctions of the kidney and/or other organs.
It is thus likely that a reduction in the ZNF407 function plays an
important role in ID pathogenesis. This is consistent with the well
established concept that abnormalities in gene expression contribute
to intellectual disability and autism [26]. Although the mechanisms re-
sponsible for the ZNF407-induced ID coupled autism remain unclear,
our observations that polymorphisms and mutations in the ZNF407
gene occur frequently in patients with both ID/autistic conditions
strongly indicate an important contribution of the ZNF407 function to
the pathogenesis of this disease. However, further investigation, includ-
ing investigation of the effects of the ZNF407 mutations on intellectual
disability, would aid in the better understanding of the underlying
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